KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹8.81 Cr | ₹-0.72 Cr | ₹7.03 Cr | ₹1.61 Cr | ₹0.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹8.81 Cr |
Mar2023 | ₹-0.72 Cr |
Mar2022 | ₹7.03 Cr |
Mar2021 | ₹1.61 Cr |
Mar2020 | ₹0.85 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹8.81 Cr | Positive | |
Mar2023 | ₹-0.72 Cr | Negative | |
Mar2022 | ₹7.03 Cr | 335.44 | |
Mar2021 | ₹1.61 Cr | 89.88 | |
Mar2020 | ₹0.85 Cr | - |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KILITCH DRUGS (INDIA) | ₹778.8 Cr | 3.6% | 2.4% | 28.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
KILITCH DRUGS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KILITCH DRUGS (INDIA) | 3.6% |
2.4% |
28.1% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses